Tafara Gapare
Out
Injury Undisclosed
2025 CBB Stats
PTS
2.9
REB
2.9
AST
0.4
STL
0.6
BLK
0.8
ROS Projections
Unavailable Tuesday
Gapare (undisclosed) won't play in Tuesday's game against Seton Hall.
ANALYSIS
Gapare will miss his third game of the season due to an unspecified injury. The backup big man is averaging 2.9 points and 2.9 rebounds across 16.3 minutes per game this season. His next chance to play will come Dec. 31 against DePaul.
Gapare will miss his third game of the season due to an unspecified injury. The backup big man is averaging 2.9 points and 2.9 rebounds across 16.3 minutes per game this season. His next chance to play will come Dec. 31 against DePaul.
College Basketball Stats
Loading CBB Stats...
2022 CBB Game Log
2025
2024
2023
2022
2025 CBB Game Log
Loading Game Log...
2025 CBB Split Stats
Loading CBB Stats...
Wildcats Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Returns in Wednesday's win
Gapare (foot) finished Wednesday's 70-55 victory over La Salle with five points (1-4 FG, 1-2 3Pt, 2-2 FT), three rebounds, one block and one steal in 20 minutes.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Sidelined Saturday
Gapare (foot) won't play in Saturday's game against Duquesne.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Out vs. Sacred Heart
Gapare (foot) won't play against Sacred Heart on Tuesday night, Villanova announced.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Healthy for second exhibition
Gapare (foot) will play in Friday's exhibition game against Virginia.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Sidelined for exhibition
Gapare has been ruled out for Sunday's exhibition against VCU due to a right foot injury.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.